This cross-sectional study uses deidentified patient information from Optum’s deidentified Integrated Claims-Clinical data set to compare frequency of opioid prescriptions for patients at risk for opioid misuse in the 18-month… Click to show full abstract
This cross-sectional study uses deidentified patient information from Optum’s deidentified Integrated Claims-Clinical data set to compare frequency of opioid prescriptions for patients at risk for opioid misuse in the 18-month periods before and after publication of the Centers for Disease Control and Prevention (CDC) opioid prescribing guideline.
               
Click one of the above tabs to view related content.